1. Radiotherapy uses ionizing radiation to kill tumor cells, with the goal of achieving permanent local tumor control or palliating symptoms.
2. External beam radiation is delivered via linear accelerators or cobalt-60 units and can treat deep or superficial tumors. Brachytherapy places radioactive sources close to the tumor.
3. Radiation damages DNA directly and indirectly via free radicals. This can lead to reproductive cell death and loss of clonogenicity. Fractionated low-dose delivery allows normal tissue recovery between fractions.
2. HISTORY
1906-1912– Dr Richard Eberlien
Not practiced in India –cost
Specialty in radiation oncology -AVMA -American College of
Veterinary Radiology
Recognized in 1994
Orthovoltage x-ray machines -cobalt-60 and cesium-137.
Cobalt and cesium -extremely dangerous and heavily regulated
Linear accelerators – late 1960s
3. INDICATIONS
Localised solid neoplasms
Choice -brain tumors, nasal tumors, other neoplasms of the head
and neck
Vertebral column & pelvic canal- only option
Soft tissues of skin and subcutis
Mediastinal cancers ,caudal abdomen and pelvic canal (thymoma,
prostatic carcinoma, and anal gland tumors)
4. Other indications
When surgery has failed
When radical surgery unable to remove whole of neoplasm
Reduction in size for surgery
Not indication in neoplasia with high incidence of metastasis
5. External beam radiation therapy
Patient evaluation- ability of patient to undergo GA , CBC ,
biochemical profile , urinalysis , thoracic radiography (3
views) ,regional lymph node biopsy ,USG.
Tumor imaging &Treatment planning –radiography , CT,
USG, nuclear scintigraphy, MRI
Tumor diagnosis and selection of therapy –histopathology
& grading determine prognosis and usefulness of therapy
Debilitated patients should not be subjected to radiotherapy
6. Nasal Tumor After Treatment, CT Scan
Nasal Tumor Before Treatment,
CT Scan
7. Cont…
Post radiation evaluation- to evaluate animals for both
tumor response and side effects in normal tissue
Evaluation at 2 nd and 4 th week after end of radiation
therapy , subsequent rechecks at 2,3,5,7,9 and 12 months and
then every 3 -6 months
8. Radio Therapy Planning
Not given as single dose
Given as divided dose spread over a period of time
(Fractioned therapy)
10-12 fractions
Each time 4-5 Gy
9. 4 r’s of Radiotherapy
Reoxygenation Repopulation
Redistribution Repair
10. Factors Influencing Radiosensitivity
Oxygenation of tumor cell ,increase proportion of cell cycling
Multiple daily treatments –reoxygenation , improve cell killing
Stage of cell division – M & G2 Most sensitive
Capacity to repair damage
Repopulation–overcome by maximal dose of radiation in shortest
possible time
11. External Beam Radiation Equipment
External beam radiation sources include beams
of X-rays, gamma rays,
or electrons delivered by either orthovoltage or
megavoltage (e.g.,
cobalt 60 and linear accelerators) radiation
therapy equipment.
Megavoltage refers to the use of higher energy
radiation, which is
defined as ≥1 million volts (MV)
12. ORTHOVOLTAGE
250–500 kV range
X-rays that are generated by bombarding a metallic target
(i.e., tungsten) with high-energy electrons
low energy radiation
maximum radiation dose deposited at the skin surface
Limited to lesions ≤2 to 3 cm in depth
Differential absorption of radiation dose in bone compared
to soft tissue(2 to 4 times-risk of bone damage or necrosis.
Short source-to-skin distance (usually 50 cm)
13. Cobalt 60
Average energy 1.25 MV- Megavoltage radiation therapy
gamma rays
“Skin-sparing” effect (0.5 cm below skin surface)
Deeply seated tumors
Source-to-skin distance -80 cm, so larger field
sizes
Thorax or abdomen- may result in unacceptable
toxicity and higher morbidity from the delivery of a radiation
dose
14.
15. Linear Accelerator
X-rays (also referred to as photons) or electron beams
Greater flexibility in treating both deep and superficial tumors
High-frequency electromagnetic waves to accelerate charged
particles
Electron energies - 4 to 30 million electron volts (MeV)
source-to-skin (or axis) distance -100 cm
16. SYSTEMIC RADIATION THERAPY
Direct injection of Isotopes into patient –
I 131 ( thyroid tumors)
Samarium 153 (bone neoplasia)
P 32 (Polycythemia)
17. Units of radiation dose
S.I. unit of absorbed radiation –gray (Gy)
Gy is absorption of 1 joule / Kg
1 Gy = 100 rad (Radiation absorbed dose)
Basic principle of radiotherapy -To kill tumor cells by ionizing
radiation
18. 4 main kVp ranges
1. Low voltage (50-120 kV)- superficial skin lesions
2. Intermediate voltage (130-150 kV)-lesions few cm beneath skin
3. Orthovoltage (160-300 kV)-deep lesion
4. Mega /Super voltage (300-1000 kV) deeper lesions
20. TELETHERAPY
General anaesthesia required
Radiation source remain at a distance from lesion
X -ray therapy units- Superficial & deep
Supervoltage therapy
Particulate beam therapy-electron , neutron/ proton beam
Radiation exposure range 50-300 centi Gy/min (400 cGy dose in 1-8 minutes)
21. BRACHYTHERAPY
Radioactive isotopes placed very close to body as implant
Surface applicators, needles , seeds or grains
Low dose rate radiation used
Surrounding tissue receives less of radiation
Iridium 192 – primary isotope
Disadvantage –isolation of patient & risk of working with radioisotopes
Permanent – 198Au ,222Rn , 125K
Removable – 192Ir , 60Co, 137Cs
22. Specific methods
1. Interstitial brachytherapy-198Au, 60Co
2. Pleisotherapy- surface brachytherapy- 90Sr
3. Systemic brachytherapy-131I,
32 P
23.
24.
25.
26. X ray therapy tube vs diagnostic X-ray
tubes
Low tube current (5-20 mA); high kVp ; long
exposure time
Stationary anode ,single large filament , large sized
focal spot(5-8mm)
Target angle greater (30 °)
Close focal object distance
More efficient heat dissipation mechanism
27. Goals of Clinical Radiation therapy
RADICAL /CURATIVE THERAPY
Decrease the number of tumor
cells to a level that achieves
permanent local tumor control
PALLIATIVE RADIOTHERAPY
Decrease the symptoms of
malignant disease
Includes all or only part of
demonstrated tumor
Staging of tumor is necessary to decide goal of therapy
28. Delivery of radiation
Earlier weekly basis / Monday-Wednesday -Friday
Current fractionation- Daily / mon-tue-wed-thur-fri
Exception – malignant melanoma- weekly/ twice weekly treatment
Palliative therapy- 3-4 weekly fractions/ 5 daily treatments during 1 week
For each fraction patient is anesthetized
Most patients 1-4 treatment fields – each taking 10-15 min
33. • DNA - primary target , single & double stranded breaks
• Direct damage (1/3rd) - DNA damage
• Indirect –Hydroxyl radical (-OH*)
Reproductive death of
cell
Clonogenicity is lost
34. RADIOSENSITIVITY
Susceptibility of tumor or normal cell to a given dose of radiation
Related to oxygen level, cell cycle position, repair mechanism, inherent radio
sensitivity
RADIORESPONSIVENESS
Measurable reduction in size of tumor after radiation
Manifestation of radiosensitivity
RADIATION CURABILITY
Measure of ability of radiation to cure a patient of tumor
Goal of therapy
36. Normal tissue response
All irradiated cells are at risk of treatment related sequelae
Radiation damage is a probability event
Even at high doses tumor cell may escape radiation induced
death
Even at low doses normal tissue may react in a dramatic
manner
37. DOSE RESPONSE CURVE
Dose response curve demonstrating
tumor control and normal tissue
complication
38. COMPLICATIONS
ACUTE LATE
EFFECTS
Acute effects- proliferating
cells of body
During /within first 3-6
months
Factors –total dose, dose
intensity (duration),volume of
tissue irradiated.
Normal sequelae & short lived
effects
Slowly proliferating tissues – Nerve
& muscle
Damage is progressive and non
reversible
Fractionated radiation therapy can
reduce risk